• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,303.61 64.14
( 0.08%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,298.76 50.34
(0.81%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.63 0.05
(0.05%)
EUR-INR
100.93 0.01
(0.01%)
GBP-INR
117.11 -0.50
(-0.43%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Rulka Electricals Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
92616
INE0R7301013
80.1437159
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RULKA
25.95
58.57
EPS(TTM)
Face Value()
Div & Yield %
5.3
10
0
 

global capital markets ltd
Fredun Pharmaceuticals standalone net profit rises 39.72% in the March 2025 quarter
Jun 11,2025
Net profit of Fredun Pharmaceuticals rose 39.72% to Rs 7.07 crore in the quarter ended March 2025 as against Rs 5.06 crore during the previous quarter ended March 2024. Sales rose 41.15% to Rs 165.44 crore in the quarter ended March 2025 as against Rs 117.21 crore during the previous quarter ended March 2024.

For the full year,net profit rose 33.23% to Rs 20.81 crore in the year ended March 2025 as against Rs 15.62 crore during the previous year ended March 2024. Sales rose 30.33% to Rs 451.71 crore in the year ended March 2025 as against Rs 346.58 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales165.44117.21 41 451.71346.58 30
OPM %10.549.53 -12.2011.22 -
PBDT9.296.80 37 32.7225.25 30
PBT8.045.84 38 28.2721.45 32
NP7.075.06 40 20.8115.62 33